✦ LIBER ✦

Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma

✍ Scribed by Parmar, S R; Bookout, R; Shapiro, J F; Tombleson, R; Perkins, J; Kim, J; Yue, B; Tomblyn, M; Alsina, M; Nishihori, T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Melphalan 1-Day Versus 2-D

✍ Parmar, Sapna; Bookout, Ryan; Shapiro, Jamie; Tombleson, Rebecca; Perkins, Janel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Cardiac toxicity of high-dose cyclophosp

✍ Samo Zver; Vesna Zadnik; Peter Černelč; Mirta Koželj 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 298 KB

A Phase 2 Study of Bortezomib Plus High-

✍ T. Nishihori; J.L. Ochoa-Bayona; J. Pidala; K. Shain; R. Baz; C.M. Simonelli; D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Pegfilgrastim compared with filgrastim a

✍ Massimo Martino; Giulia Praticò; Giuseppe Messina; Giuseppe Irrera; Elisabetta M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Cardiac Toxicity of High-Dose Cyclophosp

✍ Samo Zver; Vesna Zadnik; Matjaz Bunc; Polona Rogel; Peter Cernelc; Mirta Kozelj 📂 Article 📅 2007 🏛 Carden Jennings Publishing 🌐 English ⚖ 106 KB

Optimal Dosing of Melphalan As High-Dose

✍ Nooka, Ajay K.; Harvey, R. Donald; Langston, Amelia; Collins, Hannah; Lonial, Sa 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 403 KB